Skip to main content

Altimmune, Inc 8-K, filed Oct 27, 2026

Altimmune, Inc. (ALT)

8-K 2026-10-27 For: 2026-10-23
View Original
Added on October 27, 2026

About this 8-K

Altimmune, Inc filed this 8-K on October 27, 2026, reporting on events of October 23, 2026.

Altimmune appointed Peter Greenleaf and Alex Howarth as directors effective November 2, 2026, increasing its board from nine to eleven; John M. Gill, Mitchel Sayare, Ph.D., and Klaus O. Schafer, M.D., MPH, will retire at the 2027 Annual Meeting. AI summary

Items reported

  • Item 5.02: Director or officer change, or executive pay
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits